Importance of attributable risk in monitoring adverse events after immunization: hepatitis B vaccination in children.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 11211648.
- Also identified by PMC identifier 1446525.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Most vaccine safety data present only the postvaccination incidence of all adverse events rather than an estimate of attributable risk. This study sought to illustrate the difference between the 2 estimates with data from a hepatitis B immunization program. The incidence of health problems occurring before and after each dose of hepatitis B vaccine in a cohort of 1130 children were compared. Although 47.5% of all children reported an adverse event during the 4 weeks following each of the 3 doses, adverse events attributable to immunization occurred in only 10.6% of children. Postimmunization incidence systematically overestimates the risk of adverse events. Estimating actual attributable risk is necessary to avoid false beliefs regarding immunization.
Medical subject headings
- Adverse Drug Reaction Reporting Systems
- Data Interpretation, Statistical
- Drug Monitoring
- Hepatitis B Vaccines
- Vaccines, Synthetic